Kimberly N. Johnson

2.3k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

Kimberly N. Johnson is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kimberly N. Johnson has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Kimberly N. Johnson's work include Cancer-related Molecular Pathways (6 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Cells and Metastasis (2 papers). Kimberly N. Johnson is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Cells and Metastasis (2 papers). Kimberly N. Johnson collaborates with scholars based in United States, Germany and Canada. Kimberly N. Johnson's co-authors include Jennifer A. Pietenpol, Melinda E. Sanders, Yu Shyr, Brian D. Lehmann, Bojana Jovanović, Harold L. Moses, Xi Chen, Mónica V. Estrada, Jing Luan and Chaitanya S. Nirodi and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kimberly N. Johnson

13 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

2016 946 citations Brian D. Lehmann, Bojana Jovanović et al. PLoS ONE profile →

Peers

Countries citing papers authored by Kimberly N. Johnson

Since Specialization

Citations

This map shows the geographic impact of Kimberly N. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly N. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly N. Johnson more than expected).

Fields of papers citing papers by Kimberly N. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly N. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly N. Johnson. The network helps show where Kimberly N. Johnson may publish in the future.

Co-authorship network of co-authors of Kimberly N. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly N. Johnson. A scholar is included among the top collaborators of Kimberly N. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly N. Johnson. Kimberly N. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer 2019 ·Clinical Cancer Research ·Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders, Erica L. Mayer, Tufia C. Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R. Nangia, Paula I. González-Ericsson, Violeta Sánchez, Kimberly N. Johnson, Richard G. Abramson, Sheau‐Chiann Chen, Yu Shyr, Carlos L. Arteaga, Antonio C. Wolff, Jennifer A. Pietenpol	113
2	p73 regulates epidermal wound healing and induced keratinocyte programming 2019 ·PLoS ONE ·J. Scott Beeler, Clayton B. Marshall, Paula I. González-Ericsson, Timothy M. Shaver, (unknown), (unknown), Kimberly N. Johnson, Hailing Jin, Bryan J. Venters, Melinda E. Sanders, Jennifer A. Pietenpol	25
3	Abstract PD6-12: Evaluating racial disparities in breast cancer referrals for hereditary risk assessment 2019 ·Cancer Research ·(unknown), J.R. Peterson, R. Thomas, Kimberly N. Johnson, (unknown), Tara Biagi, (unknown)	1
4	p73 Is Required for Ovarian Follicle Development and Regulates a Gene Network Involved in Cell-to-Cell Adhesion 2018 ·iScience ·(unknown), J. Scott Beeler, Clayton B. Marshall, Timothy M. Shaver, Quanhu Sheng, Kimberly N. Johnson, Kelli L. Boyd, Bryan J. Venters, Rebecca S. Cook, Jennifer A. Pietenpol	14
5	Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection breakdown → 2016 ·PLoS ONE ·Brian D. Lehmann, Bojana Jovanović, Xi Chen, Mónica V. Estrada, Kimberly N. Johnson, Yu Shyr, Harold L. Moses, Melinda E. Sanders, Jennifer A. Pietenpol	946
6	PrimeMD, a Real-Time Symptom Management Smartphone Application for Head and Neck Cancer Patients Undergoing Radiation Therapy 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Sheila H. Ridner, Mary S. Dietrich, Kimberly N. Johnson	1
7	BM-15 * TARGETING MEK IS A NOVEL AND EFFECTIVE TREATMENT STRATEGY OF LUNG CNS METASTASIS 2014 ·Neuro-Oncology ·Kimberly N. Johnson, Gerald Gooden, P. González, (unknown), (unknown), Emanuel F. Petricoin, Mariaelena Pierobon, Sara A. Byron, J. B. Glen, Manmeet S. Ahluwalia, Mark Bernstein, Steven A. Toms, (unknown)	2
8	Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation 2010 ·Clinical Cancer Research ·Joshua A. Bauer, A. Bapsi Chakravarthy, Jennifer M. Rosenbluth, Deming Mi, Erin H. Seeley, Nara De Matos Granja-Ingram, Maria G. Olivares, Mark C. Kelley, Ingrid A. Mayer, Ingrid M. Meszoely, Julie A. Means‐Powell, Kimberly N. Johnson, C. Jillian Tsai, Gregory D. Ayers, Melinda E. Sanders, Robert J. Schneider, Silvia C. Formenti, Richard M. Caprioli, Jennifer A. Pietenpol	142
9	Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation 2010 ·Cell Death and Disease ·(unknown), Kimberly N. Johnson, (unknown), Karsten Boehnke, Yu Shyr, Petra Boukamp, Jennifer A. Pietenpol	49
10	ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy 2010 ·Molecular Cancer ·(unknown), Jennifer M. Rosenbluth, Deborah J. Mays, Clayton B. Marshall, (unknown), Seema Sinha, Kimberly N. Johnson, (unknown), Jennifer A. Pietenpol	57
11	ΔNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis 2009 ·Developmental Biology ·(unknown), Emilios Tahinci, Christopher E. Barbieri, Kimberly N. Johnson, Alison Hanson, Kristin K. Jernigan, (unknown), Ethan Lee, Jennifer A. Pietenpol	12
12	IGFBP-3 Is a Direct Target of Transcriptional Regulation by ΔNp63α in Squamous Epithelium 2005 ·Cancer Research ·Christopher E. Barbieri, Carmen A. Perez, Kimberly N. Johnson, Kim Ely, Dean Billheimer, Jennifer A. Pietenpol	58
13	Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression 1997 ·Journal of Leukocyte Biology ·Jing Luan, Rebecca L. Shattuck-Brandt, (unknown), James D. Owen, Robert M. Strieter, Marie D. Burdick, Chaitanya S. Nirodi, Dan E. Beauchamp, Kimberly N. Johnson, Ann Richmond	167

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact